LAVAZZA, CRISTIANA
LAVAZZA, CRISTIANA
Universita' degli Studi di MILANO
Finding a new therapeutic approach for no-option Parkinsonisms : Mesenchymal stromal cells for progressive supranuclear palsy
2016 M. Canesi, R. Giordano, L. Lazzari, M. Isalberti, I.U. Isaias, R. Benti, P. Rampini, G. Marotta, A. Colombo, E. Cereda, M. Dipaola, T. Montemurro, M. Viganò, S. Budelli, E. Montelatici, C. Lavazza, A. Cortelezzi, G. Pezzoli
Dissection of the cord blood stromal component reveals predictive parameters for culture outcome
2015 M. Barilani, C. Lavazza, M. Vigano', T. Montemurro, V. Boldrin, V. Parazzi, E.G.A. Montelatici, M. Crosti, M. Moro, R. Giordano, L. Lazzari
Defining the identity of human adipose-derived mesenchymal stem cells
2015 E. Montelatici, B. Baluce, E. Ragni, C. Lavazza, V. Parazzi, R. Mazzola, G. Cantarella, M. Brambilla, R. Giordano, L. Lazzari
Targeting TRAIL Receptors with Genetically-Engineered CD34+ Hematopoietic Stem Cells
2011 C. Carlo-Stella, A.M. Gianni, A. Giacomini, C. Lavazza, S.L. Locatelli
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor–related apoptosis-inducing ligand target both tumor cells and tumor vasculature
2010 C. Lavazza, C. Carlo Stella, A. Giacomini, L. Cleris, M. Righi, D. Sia, M. Di Nicola, M. Magni, P. Longoni, M. Milanesi, M. Francolini, A. Gloghini, A. Carbone, F. Formelli, A.M. Gianni
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments
2009 M. Righi, A. Giacomini, C. Lavazza, D. Sia, C. Carlo-Stella, A. Gianni
Anticancer cell therapy with TRAIL-armed CD34+ progenitor cells
2008 C. Carlo Stella, C. Lavazza, A. Carbone, A.M. Gianni
Antitumor activity of adenovirally transduced CD34+ cells expressing membrane-bound TRAIL
2007 C. Carlo Stella, C. Lavazza, A. Carbone, A.M. Gianni
Targeting Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Agonistic Receptors for Cancer Therapy
2007 C. Carlo-Stella, C. Lavazza, A. Locatelli, L. Viganò, A.M. Gianni, L. Gianni
Highly efficient gene transfer into mobilized CD34+ hematopoietic cells using serotype-5 adenoviral vectors and BoosterExpress™ Reagent
2007 C. Lavazza, C. Carlo-Stella, M. Di Nicola, P. Longoni, M. Milanesi, M. Magni, A.M. Gianni
Interferon γ enhances the anti-myeloma activity of the fully human anti-HLA-DR monoclonal antibody 1D09C3
2007 C. Carlo-Stella, A. Guidetti, M. Di Nicola, C. Lavazza, L. Cleris, D. Sia, P. Longoni, M. Milanesi, M. Magni, Z. Nagy, P. Corradini, A. Carbone, F. Formelli, A.M. Gianni
Forced Expression of RDH10 Gene Retards Growth of HepG2 Cells
2007 E. Rossi, P. Picozzi, B. Bodega, C. Lavazza, C. Carlo-Stella, A. Marozzi, E. Ginelli
Placental Growth Factor-1 Potentiates Hematopoietic Progenitor Cell Mobilization Induced by Granulocyte Colony-Stimulating Factor in Mice and Nonhuman Primates
2007 C. Carlo-Stella, M. Di Nicola, P. Longoni, L. Cleris, C. Lavazza, R. Milani, M. Milanesi, M. Magni, V. Pace, F. Colotta, M.A. Avanzini, F. Formelli, A.M. Gianni
The anti-HLA-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing NOD/SCID mice
2006 C. Carlo-Stella, M. Di Nicola, M.C. Turco, L. Cleris, C. Lavazza, P. Longoni, M. Milanesi, M. Magni, M. Ammirante, A. Leone, Z. Nagy, W.R. Gioffrè, F. Formelli, A.M. Gianni
Antitumor Activity of Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (mTRAIL)
2006 C.C. Stella, C. Lavazza, M. Di Nicola, L. Cleris, P. Longoni, M. Milanesi, M. Magni, D. Morelli, A. Gloghini, A. Carbone, A.M. Gianni
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice
2006 C. Carlo-Stella, A. Guidetti, M. Di Nicola, P. Longoni, L. Cleris, C. Lavazza, M. Milanesi, R. Milani, M. Carrabba, L. Farina, F. Formelli, A.M. Gianni, P. Corradini
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (mTRAIL)
2006 C. Carlo-Stella, C. Lavazza, M. Di Nicola, L. Cleris, P. Longoni, M. Milanesi, M. Magni, D. Morelli, A. Gloghini, A. Carbone, A.M. Gianni
Uso di cellule staminali geneticamente modificate ad esprimere TNF-RELATED apoptosis-inducing ligand (TRAIL) per il trattamento di linfomi disseminati
2005 C. Lavazza
Primary Plasma Cells Expressing CD52 Are Efficiently Targeted In Vivo by Alemtuzumab
2004 C. Carlo Stella, M. Di Nicola, P. Longoni, L. Cleris, M. Milanesi, C. Lavazza, R. Milani, M. Carrabba, F. Formelli, A.M. Gianni, P. Corradini
In Vitro and In Vivo Anti-Lymphoma Activity of the Anti-HLA-DR Monoclonal Antibody 1D09C3
2004 C. Carlo Stella, M. Di Nicola, C. Turco, L. Cleris, C. Lavazza, M. Milanesi, P. Longoni, E. Zorzan, M. Magni, M. Ammirante, A. Leone, F. Formelli, A.M. Gianni